Sun, Yi

Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., Nikolovska-Coleska, Z., Ding, K., Wang, G., Chen, J., et al. (2008) · Proceedings of the National Academy of Sciences

Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 660

Protein neddylation and its role in health and diseases

Zhang, S., Yu, Q., Li, Z., Zhao, Y., & Sun, Y. (2024) · Signal Transduction and Targeted Therapy

Ubiquitin and proteasome pathwaysProtein Degradation and Inhibitors

Cited by 171

Ca2+signals promote GLUT4 exocytosis and reduce its endocytosis in muscle cells

Li, Q., Zhu, X., Ishikura, S., Zhang, D., Gao, J., Sun, Y., Contreras-Ferrat, A., Foley, K. P., Lavandero, S., Yao, Z., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism

Metabolism, Diabetes, and CancerCellular transport and secretion

Cited by 41

Overcoming Resistance to AC0010, a Third Generation of EGFR Inhibitor, by Targeting c-MET and BCL-2

Xu, W., Tang, W., Li, T., Zhang, X., & Sun, Y. (2019) · Neoplasia

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 23